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Background
Questions addressed in this study included: ''What Gag
mutations are most frequent in primary HIV-1C infec-
tion?'', ''When do these mutations occur in relation to the
estimated time of seroconversion?'', and ''How are these
mutations associated with MHC class I HLA alleles?''
Methods
A total of 42 subjects (8 acutely and 34 recently HIV-
infected individuals with estimated time of seroconver-
sion) were included. Gag quasispecies were analyzed by
single-genome amplification/sequencing. Ten amino acid
positions across Gag with the most frequent mutations
were chosen for analysis. Mutations were analyzed at fre-
quent time points (median 4.5 per subject; IRQ 3.0; 6.0).
High-resolution typing was performed within HLA-A, -B,
and -C loci. Gag mutations toward the wild type were
treated as reversions and mutations from the wild type as
escapes. Mutations were classified as minor, transient,
dominant, or complete.
Results
The most frequent mutations were found in p17 (position
28), p24 (positions 242, 269), and p2/p7/p1/p6 (posi-
tions 370, 411, 428, 431, 449, 459, 471). Most of the
observed Gag mutations fit or could be explained by pre-
viously described CTL/CD8+ epitopes, although MHC
class I HLA alleles expressed by analyzed subjects did not
necessarily match previously reported HLA restriction.
Timing and patterns of viral mutations at position 242
matched clearly with the presence or absence of HLA-
B*57/5801. A high frequency of transient mutations in
Gag was evident at positions 28, 431, 449, and 471, where
the observed mutations were minor or were lost soon after
appearance.
Conclusion
Distribution of Gag mutations revealed the dominance of
the most frequent Gag mutations within p2/p7/p1/p6,
which was in line with the viral diversity within Gag cleav-
age products. Analysis of MHC class I HLA alleles implied
broader HLA restriction of involved CTL/CD8+ epitopes.
The transient nature of many observed mutations in Gag
suggested their lower fitness, apparently due to structural
and functional constraints.
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